Health Catalyst, Inc.HCATNASDAQ
Loading
R&D Expenses Over TimeContracting
Percentile Rank38
3Y CAGR-13.0%
5Y CAGR-1.4%
Studio
Year-over-Year Change

Research and development spending

3Y CAGR
-13.0%/yr
vs +18.3%/yr prior
5Y CAGR
-1.4%/yr
Recent deceleration
Acceleration
-31.4pp
Decelerating
Percentile
P38
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
3 yr
Consecutive declineContracting
PeriodValueYoY Change
2025$49.77M-14.1%
2024$57.95M-20.2%
2023$72.63M-4.0%
2022$75.68M+20.6%
2021$62.73M+17.2%
2020$53.52M+15.7%
2019$46.25M+19.8%
2018$38.59M+35.6%
2017$28.47M-